Translational hurdles in anti-asthmatic nanomedicine development
[No abstract available]
Published in: | Expert Opinion on Drug Delivery |
---|---|
Main Author: | Akram M.W.; Wong T.W. |
Format: | Editorial |
Language: | English |
Published: |
Taylor and Francis Ltd.
2024
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85200027237&doi=10.1080%2f17425247.2024.2385092&partnerID=40&md5=f081bae11ad086d0aa1618cf5018d5dc |
Similar Items
-
Critical clinical gaps in cancer precision nanomedicine development
by: Gan W.W.; Chan L.W.; Li W.; Wong T.W.
Published: (2022) -
Exosomes-based nanomedicines for cancer immunotherapy
by: Hussain Z.; Alrimi W.M.; Elsaid R.E.; Alkaabi O.A.; Thu H.E.; Khan S.; Sohail M.; Sarfraz R.M.; Mahmood A.
Published: (2024) -
A Systematic Review of Translator Translation Styles: Trends and Development from 2013 to 2023
by: Yang J.; Husin N.
Published: (2024) -
A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers
by: Rasul R.M.; Tamilarasi Muniandy M.; Zakaria Z.; Shah K.; Chee C.F.; Dabbagh A.; Rahman N.A.; Wong T.W.
Published: (2020) -
Natural Product-based Nanomedicine: Recent Advances and Issues for the Treatment of Alzheimer's Disease
by: Woon C.K.; Hui W.K.; Abas R.; Haron M.H.; Das S.; Lin T.S.
Published: (2022)